Tumor protein p53 is long known to be a critical factor in suppressing tumorigenesis and initiating apoptosis; its pro-apoptotic property might render it a promising target in PAD given multiple clinical observations of the increased level of apoptotic events in the serum and tissue of PAD and CAD (coronary artery disease) patients [160–163]. Here, TP53 is linked to peripheral arterial disease.